Phenanthroline

Phenanthroline

SCHEMBL1237620

Cl.[Ru].c1cnc2c(c1)ccc1cccnc12.c1cnc2c(c1)ccc1cccnc12.c1cnc2c(c1)ccc1cccnc12

nearest known ligand 0.89

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Phenanthroline. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR5 known ✓ P51681 3/20 0.89
HSP90AA1 known ✓ P07900 1/20 0.89
MMP8 known ✓ P22894 1/20 0.89
MMP13 known ✓ P45452 1/20 0.89
CHRM1 known ✓ P11229 1/20 0.56
ADRA1A known ✓ P35348 1/20 0.56
HDAC8 known ✓ Q9BY41 1/20 0.56
CA2 known ✓ P00918 1/20 0.47
PARP1 known ✓ P09874 1/20 0.47
CCR1 P32246 5/20 0.89
CCR8 P51685 5/20 0.89
LMNA P02545 4/20 0.89
KDM4E B2RXH2 3/20 0.89
MMP2 P08253 2/20 0.89
TSHR P16473 2/20 0.89
MAPT P10636 2/20 0.89
HTT P42858 2/20 0.89
SMN1; SMN2 Q16637 2/20 0.89
TDP1 Q9NUW8 2/20 0.89
GMNN O75496 1/20 0.89

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenanthroline SCHEMBL5461212 0.97 CCR1 (0.84) CCR1CCR8LMNACCR5KDM4E
Phenanthroline SCHEMBL28973442 0.97 CCR1 (0.94) CCR1CCR8LMNACCR5KDM4E
Phenanthroline SCHEMBL29367240 0.97 CCR1 (0.94) CCR1CCR8LMNACCR5KDM4E
Phenanthroline SCHEMBL5347299 0.97 CCR1 (0.94) CCR1CCR8LMNACCR5KDM4E
Phenanthroline SCHEMBL7268958 0.97 CCR1 (0.94) CCR1CCR8LMNACCR5KDM4E
Phenanthroline SCHEMBL725644 0.97 CCR1 (0.94) CCR1CCR8LMNACCR5KDM4E
Phenanthroline SCHEMBL1681332 0.97 CCR1 (0.94) CCR1CCR8LMNACCR5KDM4E
Phenanthroline SCHEMBL29401908 0.97 CCR1 (0.94) CCR1CCR8LMNACCR5KDM4E
Phenanthroline SCHEMBL345410 0.97 CCR1 (0.94) CCR1CCR8LMNACCR5KDM4E
Phenanthroline SCHEMBL31040598 0.97 CCR1 (0.94) CCR1CCR8LMNACCR5KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-6256368-A None JP disclosed
US-7961315-B2 Fluorescence detection enhancement using photonic crystal extraction THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2011-06-14 US disclosed
US-20110031409-A1 Fluorescence detection enhancement using photonic crystal extraction THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS 2011-02-10 US disclosed
US-7768640-B2 Fluorescence detection enhancement using photonic crystal extraction THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2010-08-03 US disclosed
US-20100055666-A1 BIOSENSOR WITH EVANESCENT WAVEGUIDE AND INTEGRATED SENSOR KONINKLIJKE PHILIPS ELECTRONICS N.V. (NL) 2010-03-04 US disclosed
EP-2137529-A1 CALIBRATION AND NORMALIZATION METHOD FOR BIOSENSORS SRU Biosystems, Inc. (US) 2009-12-30 EP disclosed
EP-2115433-A1 BIOSENSOR WITH EVANESCENT WAVEGUIDE AND INTEGRATED SENSOR Koninklijke Philips Electronics N.V. (NL) 2009-11-11 EP disclosed
US-7558446-B2 All polymer optical waveguide sensor KONINKLIJKE PHILIPS ELECTRONICS N.V. (NL) 2009-07-07 US disclosed
US-20080278722-A1 Fluorescence detection enhancement using photonic crystal extraction THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS 2008-11-13 US disclosed
WO-2008136812-A2 FLUORESCENCE DETECTION ENHANCEMENT USING PHOTONIC CRYSTAL EXTRACTION THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2008-11-13 WO disclosed
US-20060051830-A1 Quantitation of enzyme activity using planar waveguides BAYER HEALTHCARE LLC 2006-03-09 US disclosed
EP-0760944-B1 PROCESS FOR DETECTING EVANESCENTLY EXCITED LUMINESCENCE NOVARTIS AG (CH) 2002-04-17 EP disclosed
US-5959292-A Process for detecting evanescently excited luminescence NOVARTIS CORPORATION (US) 1999-09-28 US disclosed
EP-0759159-B1 PROCESS AND SENSOR FOR DETECTING EVANESCENTLY EXCITED LUMINESCENCE CIBA GEIGY AG (CH) 1998-10-14 EP disclosed
US-5822472-A Process for detecting evanescently excited luminescence NOVARTIS CORPORATION (US) 1998-10-13 US disclosed
EP-0760944-A1 PROCESS FOR DETECTING EVANESCENTLY EXCITED LUMINESCENCE Novartis AG (CH) 1997-03-12 EP disclosed
EP-0759159-A1 PROCESS FOR DETECTING EVANESCENTLY EXCITED LUMINESCENCE Novartis AG (CH) 1997-02-26 EP disclosed
WO-1995033197-A1 PROCESS FOR DETECTING EVANESCENTLY EXCITED LUMINESCENCE CIBA-GEIGY AG (CH) 1995-12-07 WO disclosed
WO-1995033198-A1 PROCESS FOR DETECTING EVANESCENTLY EXCITED LUMINESCENCE CIBA-GEIGY AG (CH) 1995-12-07 WO disclosed
JP-H06256368-A PRODUCTION OF TRIS(1,10-PHENANTHROLINE) RUTHENIUM CHLORIDE TANAKA KIKINZOKU KOGYO KK 1994-09-13 JP disclosed